Literature DB >> 3893594

Oxidised regenerated cellulose: an effective emergency haemostatic in burns surgery.

E Z Hazarika.   

Abstract

A 26-year-old man with 40% full-thickness burns was treated by excision and split-skin grafting on the 7th post-burn day. He developed bleeding 1 hour post-operatively which persisted despite the use of pressure dressings, elevation of the limbs, the administration of fresh frozen plasma, platelet-rich plasma, calcium, whole blood and cryoprecipitate respectively over a period of 11 hours. The bleeding was finally controlled under general anaesthesia by clot removal, bipolar electro-coagulation of miniscule oozing points, replacement of the meshed skin graft and the application of a layer of oxidised regenerated cellulose over the grafted area. The properties and uses of oxidised regenerated cellulose are outlined.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3893594     DOI: 10.1016/0007-1226(85)90256-5

Source DB:  PubMed          Journal:  Br J Plast Surg        ISSN: 0007-1226


  3 in total

1.  Magnetic resonance imaging appearance of oxidized regenerated cellulose in breast cancer surgery.

Authors:  Michela Giuliani; Rossella Rella; Rita Fubelli; Federica Patrolecco; Silvia Eleonora Di Giovanni; Chiara Buccheri; Federico Padovano; Paolo Belli; Maurizio Romani; Pierluigi Rinaldi; Enida Bufi; Gianluca Franceschini; Lorenzo Bonomo
Journal:  Radiol Med       Date:  2016-06-04       Impact factor: 3.469

2.  Effectiveness of collagen/oxidised regenerated cellulose/silver-containing composite wound dressing for the treatment of medium-depth split-thickness skin graft donor site wounds in multi-morbid patients: a prospective, non-comparative, single-centre study.

Authors:  Alexander Konstantinow; Tatjana V Fischer; Johannes Ring
Journal:  Int Wound J       Date:  2016-12-01       Impact factor: 3.315

3.  Oxidized regenerated cellulose resembling vaginal cuff abscess.

Authors:  Teresa Tam; Gerald Harkins; Thomas Dykes; Allison Gockley; Matthew Davies
Journal:  JSLS       Date:  2014 Apr-Jun       Impact factor: 2.172

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.